Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
finance.yahoo.com · 2026-09-13
Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one. The case for each is stronger than most comparisons admit, and the tiebreaker comes down to a single question about your timeline.
TickrTrends take: Medtronic's positioning alongside Abbott in discussions of dividend-paying medical device companies reflects investor interest in the Healthcare sector's income potential. With TickrTrends assessing MDT as fairly valued, the relative comparison between these two dividend giants becomes a relevant consideration for investors evaluating whether MDT offers appropriate compensation for its risk profile at current levels. For valuation-focused readers, tracking how MDT's dividend yield and payout sustainability compare to peers operating in the same sector may help identify whether the fair valuation assessment remains appropriate over time.
Read the full story at finance.yahoo.com →
Is MDT undervalued? See TickrTrends' fair value analysis →